NO20025329L - Virulensgener, proteiner og deres anvendelse - Google Patents
Virulensgener, proteiner og deres anvendelseInfo
- Publication number
- NO20025329L NO20025329L NO20025329A NO20025329A NO20025329L NO 20025329 L NO20025329 L NO 20025329L NO 20025329 A NO20025329 A NO 20025329A NO 20025329 A NO20025329 A NO 20025329A NO 20025329 L NO20025329 L NO 20025329L
- Authority
- NO
- Norway
- Prior art keywords
- genes
- proteins
- virulence genes
- virulence
- products
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000001018 virulence Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/36—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0011108.8A GB0011108D0 (en) | 2000-05-08 | 2000-05-08 | Virulence gene and protein and their use |
PCT/GB2001/002003 WO2001085772A2 (en) | 2000-05-08 | 2001-05-08 | Virulence genes, proteins, and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025329D0 NO20025329D0 (no) | 2002-11-06 |
NO20025329L true NO20025329L (no) | 2003-01-06 |
Family
ID=9891203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025329A NO20025329L (no) | 2000-05-08 | 2002-11-06 | Virulensgener, proteiner og deres anvendelse |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040087770A1 (no) |
EP (2) | EP1908839A3 (no) |
JP (1) | JP2003532404A (no) |
KR (3) | KR20030032948A (no) |
CN (2) | CN1840665A (no) |
AT (1) | ATE382056T1 (no) |
AU (1) | AU776508B2 (no) |
CA (1) | CA2408738A1 (no) |
CZ (1) | CZ20023642A3 (no) |
DE (1) | DE60132084T2 (no) |
GB (1) | GB0011108D0 (no) |
HU (1) | HUP0302481A2 (no) |
NO (1) | NO20025329L (no) |
NZ (3) | NZ522277A (no) |
RU (2) | RU2252224C2 (no) |
WO (1) | WO2001085772A2 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996017951A2 (en) | 1994-12-09 | 1996-06-13 | Rpms Technology Limited | Identification of genes responsible for in vivo survival of microorganisms |
DK1108034T3 (da) | 1998-09-04 | 2008-11-10 | Emergent Product Dev Uk Ltd | Svækkede salmonella SPI2-mutanter som antigenbærere |
EP1163343B1 (en) | 1999-03-12 | 2009-12-09 | GlaxoSmithKline Biologicals S.A. | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
GB9910812D0 (en) | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
KR101239242B1 (ko) * | 2002-08-02 | 2013-03-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 항원 조합물을 포함하는 나이세리아 백신 조성물 |
GB0330007D0 (en) * | 2003-12-23 | 2004-01-28 | Imp College Innovations Ltd | Vaccines |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
CN102716480B (zh) | 2005-04-08 | 2023-03-21 | 惠氏有限责任公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物 |
AU2008304231A1 (en) * | 2007-09-27 | 2009-04-02 | Albany Molecular Research, Inc. | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
EP2326344A4 (en) | 2008-06-16 | 2013-08-07 | Prokarium Ltd | VACCINES WITH SALMONELLA VECTOR AGAINST CHLAMYDIA AND METHOD OF ADMINISTRATION |
GB0816447D0 (en) * | 2008-09-08 | 2008-10-15 | Glaxosmithkline Biolog Sa | Vaccine |
CA2792691A1 (en) * | 2010-03-11 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Immunogenic composition or vaccine against gram-negative bacterial, for example, neisserial, infection or disease |
CN111118043B (zh) * | 2020-01-13 | 2022-07-05 | 吉林大学 | 一种苦豆子SaMET6基因克隆及其应用 |
CN116042562B (zh) * | 2022-03-11 | 2023-10-20 | 山东恒鲁生物科技有限公司 | 重组酵母菌及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2047043A1 (en) * | 1990-07-19 | 1992-01-20 | Allen I. Oliff | Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
US5338664A (en) * | 1992-12-04 | 1994-08-16 | American Cyanamid Company | Assay for detection of bacterial iron transport inhibitors |
US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
WO1996017951A2 (en) * | 1994-12-09 | 1996-06-13 | Rpms Technology Limited | Identification of genes responsible for in vivo survival of microorganisms |
FR2751000B1 (fr) * | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
US6472518B1 (en) * | 1996-10-24 | 2002-10-29 | Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services | Invasion associated genes from Neisseria meningitidis serogroup B |
GB9711964D0 (en) * | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
DE69836333T2 (de) * | 1997-08-15 | 2007-04-19 | Rijksuniversiteit Utrecht | Neisseria lactoferrin-bindendes protein |
CA2308606A1 (en) * | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
AU3968599A (en) * | 1998-04-29 | 1999-11-16 | American Cyanamid Company | Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis |
GB9811260D0 (en) * | 1998-05-26 | 1998-07-22 | Smithkline Beecham Biolog | Novel compounds |
JP2004511201A (ja) * | 1998-10-09 | 2004-04-15 | カイロン コーポレイション | ナイセリアゲノム配列およびそれらの使用方法 |
US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
DK1185691T3 (da) * | 1999-04-30 | 2009-06-22 | Novartis Vaccines & Diagnostic | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf |
-
2000
- 2000-05-08 GB GBGB0011108.8A patent/GB0011108D0/en not_active Ceased
-
2001
- 2001-05-08 CN CNA2005101362903A patent/CN1840665A/zh active Pending
- 2001-05-08 US US10/275,026 patent/US20040087770A1/en not_active Abandoned
- 2001-05-08 CZ CZ20023642A patent/CZ20023642A3/cs unknown
- 2001-05-08 CN CN01809191A patent/CN1427892A/zh active Pending
- 2001-05-08 AT AT01925742T patent/ATE382056T1/de not_active IP Right Cessation
- 2001-05-08 RU RU2002132891/13A patent/RU2252224C2/ru not_active IP Right Cessation
- 2001-05-08 NZ NZ522277A patent/NZ522277A/en unknown
- 2001-05-08 DE DE60132084T patent/DE60132084T2/de not_active Expired - Fee Related
- 2001-05-08 WO PCT/GB2001/002003 patent/WO2001085772A2/en active IP Right Grant
- 2001-05-08 AU AU52422/01A patent/AU776508B2/en not_active Ceased
- 2001-05-08 HU HU0302481A patent/HUP0302481A2/hu unknown
- 2001-05-08 JP JP2001582371A patent/JP2003532404A/ja active Pending
- 2001-05-08 NZ NZ549068A patent/NZ549068A/en unknown
- 2001-05-08 EP EP07114502A patent/EP1908839A3/en not_active Withdrawn
- 2001-05-08 EP EP01925742A patent/EP1287024B1/en not_active Expired - Lifetime
- 2001-05-08 CA CA002408738A patent/CA2408738A1/en not_active Abandoned
- 2001-05-08 KR KR1020027014876A patent/KR20030032948A/ko not_active Application Discontinuation
- 2001-05-08 NZ NZ532297A patent/NZ532297A/en unknown
-
2002
- 2002-11-06 NO NO20025329A patent/NO20025329L/no not_active Application Discontinuation
-
2005
- 2005-01-24 RU RU2005101623/13A patent/RU2005101623A/ru not_active Application Discontinuation
-
2007
- 2007-08-17 US US11/893,649 patent/US20080241151A1/en not_active Abandoned
- 2007-08-29 KR KR1020070087191A patent/KR20070102447A/ko not_active Application Discontinuation
-
2008
- 2008-07-10 KR KR1020080067099A patent/KR20080080069A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2408738A1 (en) | 2001-11-15 |
EP1287024B1 (en) | 2007-12-26 |
AU776508B2 (en) | 2004-09-09 |
RU2005101623A (ru) | 2006-07-10 |
NO20025329D0 (no) | 2002-11-06 |
NZ522277A (en) | 2004-05-28 |
KR20070102447A (ko) | 2007-10-18 |
WO2001085772A2 (en) | 2001-11-15 |
AU5242201A (en) | 2001-11-20 |
DE60132084D1 (de) | 2008-02-07 |
NZ532297A (en) | 2005-07-29 |
HUP0302481A2 (hu) | 2003-10-28 |
US20040087770A1 (en) | 2004-05-06 |
KR20030032948A (ko) | 2003-04-26 |
US20080241151A1 (en) | 2008-10-02 |
EP1908839A3 (en) | 2008-07-16 |
CZ20023642A3 (cs) | 2003-04-16 |
WO2001085772A3 (en) | 2002-03-28 |
CN1427892A (zh) | 2003-07-02 |
RU2252224C2 (ru) | 2005-05-20 |
EP1287024A2 (en) | 2003-03-05 |
KR20080080069A (ko) | 2008-09-02 |
EP1908839A2 (en) | 2008-04-09 |
CN1840665A (zh) | 2006-10-04 |
DE60132084T2 (de) | 2008-12-11 |
GB0011108D0 (en) | 2000-06-28 |
JP2003532404A (ja) | 2003-11-05 |
NZ549068A (en) | 2008-03-28 |
ATE382056T1 (de) | 2008-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025329D0 (no) | Virulensgener, proteiner og deres anvendelse | |
IS6895A (is) | Aðferð til að bera kennsl á, einangra og vinna mótefnavaka við ákveðnum sjúkdómsvaldi | |
DE69932717D1 (de) | Methoden und produkte zur induzierung mukosaler immunität | |
CY1107950T1 (el) | Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι | |
DE69926729D1 (de) | Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert | |
NO20032111L (no) | Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter | |
NO20050063L (no) | 2-heteroaryl karboksamider | |
NZ515936A (en) | Antigenic Neisserial peptides | |
GB0121998D0 (en) | Attenuated bacteria useful in vaccines | |
NO20023006L (no) | Virulens gener, proteiner og deres anvendelse | |
DK1471936T3 (da) | HIV-Vaccine og fremgangsmåde til anvendelse | |
ATE269104T1 (de) | Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert | |
NO20062469L (no) | Streptococcus phocae vaksine | |
NO20013102D0 (no) | Gener, proteiner og deres anvendelse | |
DE602005025202D1 (de) | Subtilasevarianten mit veränderter immunogenität | |
DE60126765D1 (de) | Virulenz gene, proteine, und ihre verwendung | |
WO2002016612A3 (en) | Genes and proteins, and their uses | |
DK1074266T3 (da) | Levende svækkede bakterier til anvendelse i vaccine | |
DK1763515T3 (da) | 4-Triflourmethoxyphenoxybenzen-4'-sulfonsyrer, fremgangsmåde til deres fremstilling og anvendelse i lægemidler | |
DK1313850T3 (da) | Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer | |
DK1423429T3 (da) | Antistoffer mod caspase-8 og deres fremstilling og anvendelse | |
DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
BR0308180A (pt) | protéinas de superfìcie de leptospira | |
WO2004057018A3 (en) | Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use | |
DE3856199T2 (de) | Impfstoff gegen cholera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |